 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/680870
Xience V - Leapfrogging To Lead DES Market In The US
|
Description: |
Xience V - Leapfrogging To Lead DES Market In The US
Summary
GlobalData viewpoints are an essential source of high quality information on all key events in the medical equipment industry. GlobalData viewpoints are typically our opinion on the key events, strategic rationale and its impact on the future outlook of the medical equipment sectors. GlobalData viewpoints cover financial deals and their impact on the competitive landscape, impact of product approvals on existing market segments, emerging technologies and products in develoopment, reimbursement policies and impact on procedure numbers, government policies and reforms to make devices safer and effective through regulatory changes.
Scope
- Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on market size (historic and forecast), procedure numbers, pricing trends and competitive landscape - Viewpoints provide in depth analysis of market drivers, restraints and trends impacting the future of the sectors and sub-sectors - Viewpoints are analytical alerts that provide information on emerging technologies and products in development by sector with commentaries on clinical trial outcomes and commercialization plans
Reasons to Buy
- Be abreast of key events in the medical device industry - Make informed decisions by understanding the rationale behind key events - Align your market strategies with the events which can impact your business - Develop proactive marketing strategies and business plans through real-time updates of pipeline products, technologies and financial deals
|
|
Contents: |
1 2 1.1 List of Figures 4 2 GlobalData Viewpoint 5 2.1 Summary 5 3 Xience V - Leapfrogging to Lead DES Market in the US 6 3.1 Xience’s Success 6 3.1.1 Strong Scientific Basis 6 3.1.2 SPIRIT Trials - Strong Clinical Data Support 6 3.2 Milestones for Xience in 2007 7 3.2.1 Gender Specific Trial 7 3.2.2 Transcatheter Cardiovascular Therapeutics 2007 8 3.2.3 FDA Advisory Committee Recommends Approval of Xience V 8 3.2.4 Xience Gains Reimbursement Approval in France 8 3.3 Outlook and Implications 8 4 Recent Developments 9 4.1 Study in JAMA Shows Patients Treated With Abbotts XIENCE V Drug Eluting Stent Experience Better Outcomes 9 4.1.1 Boston Scientific Receives Canadian Approval for TAXUS Liberte Stent System 9 5 Appendix 10 5.1 Methodology 10 5.1.1 Coverage 10 5.1.2 Secondary Research 11 5.1.3 Primary Research 11 5.1.4 Models 12 5.1.5 Forecasts 12 5.1.6 Expert Panel Validation 13 5.2 Contact Us 13 5.3 About Us 13 5.4 Disclaimer 13
Executive Summary
1.1 List of Figures Figure 1: Meta-Analysis of 12-Month Data from SPIRIT II and III, 2007 7 Figure 2: GlobalData Methodology 10 |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/680870
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 29/11/2009 17:14:27 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Xience V - Leapfrogging To Lead DES Market In The US
|
|
Web Address: |
http://www.researchandmarkets.com/reports/680870
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€336.00
|
|
Electronic (PDF)
- Site License
|
|
€672.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€1,007.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 29/11/2009 17:14:27
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|